A possible structural determinant of selectivity of boldine and derivatives for the α1A-adrenoceptor subtype

British Journal of Pharmacology

Volumn 119, Issue 8, 1996, Pages 1563-1568

  Madrero, Y ^a   Elorriaga, M ^a   Martinez, S ^a   Noguera, M A ^a   Cassels, B K ^b   D'Ocon, P ^a   Ivorra, M D ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Aporphine alkaloids; Boldine; Glaucine; Predicentrine; Rat cerebral cortex

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; APORPHINE DERIVATIVE; BENOXATHIAN; BOLDINE; CHLOROETHYLCLONIDINE; GLAUCINE; PRAZOSIN; PREDICENTRINE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BRAIN CORTEX; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FEMALE; NONHUMAN; PRIORITY JOURNAL; RADIOASSAY; RAT; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIOXIDANTS; APORPHINES; BINDING, COMPETITIVE; CEREBRAL CORTEX; DIOXANES; FEMALE; OXATHIINS; PRAZOSIN; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0030462634     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16073.x     Document Type: Article

References (52)

1. 1-adrenoceptor mediating contractions of rat aorta, vas deferent and spleen. Br. J. Pharmacol., 109, 80-87.
2. ASENSIO, M., CASSELS, B.K. & SPEISKY, H. (1993). The methylation of boldine with diazomethane. Bol. Soc. Chil. Quím., 38, 331-334.
3. 1-Adrenoceptor subtypes in tissues of the rat and guinea-pig. Br. J. Pharmacol., 96, 154P.
4. 1C-adrenoceptor: studies in the isolated perfused kidney of rat. Br. J. Pharmacol., 115, 283-294.
5. 1-adrenoceptors. Eur. J. Pharmacol.-Mol. Pharmacol. Sec., 172, 131-145.
6. BOLTON, T.B. (1979). Mechanism of action of transmitters and other substances on smooth muscle. Physiol. Rev., 85, 606-719.
7. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal. Biochem., 72, 248-254.
8. CHULIA, S., IVORRA, M.D., LUGNIER, C., VILA, E., NOGUERA, M.A. & D'OCON, P. (1994). Mechanism of the cardiovascular activity of laudanosine: comparison with papaverine and other benzylisoquinolines. Br. J. Pharmacol., 113, 1377-1385.
9. 1-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A., 85, 7159-7163.
10. CUMISKEY, W.R. & FEIGENSON, M.E. (1983). Spasmolityc activity of cinnamedrine and papaverine in isolated rat uterine muscle. Arch. Int. Pharmacodyn. Ther., 263, 113-119.
11. 1B-adrenoceptor subtypes in vas deferent, kidney and aorta of the rat. Eur. J. Pharmacol., 224, 125-136.
12. 1-adrenoceptor classification. Eur. J. Pharmacol.-Mol. Pharmacol. Sec., 268, 141-149.
13. 1-Adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol. Sci., 15, 167-170.
14. 3H]-methylurapidil. Eur. J. Pharmacol.-Mol. Pharmacol. Sec., 172, 329-337.
15. 1-adrenoceptor. Eur. J. Pharmacol., 151, 333-335.
16. 1-adrenergic receptors revealed by chlorethylclonidine. Mol. Pharmacol., 32, 505-510.
17. 2+ in smooth muscle. Nature, 329, 333-335.
18. 1-adrenergic receptor binding sites in rat tissues. Mol. Pharmacol., 40, 531-538.
19. 1-adrenoceptors binding sites in the rat heart-subtype selective agonists and antagonists. Br. J. Pharmacol., 98, 652P.
20. 1-adrenoceptors recognition sites by urapidil derivatives and other selective antagonists. Br. J. Pharmacol., 97, 691-700.
21. 3H]-prazosin bindings sites. J. Pharm. Pharmacol., 41, 714-716.
22. 1-adrenoceptors: consensus update. Pharmacol. Rev., 47, 267-270.
23. 2+ channels. Eur. J. Pharmacol., 231, 165-174.
24. 1-adrenoceptor and benzothiazepine binding site at the calcium channel. Br. J. Pharmacol., 106, 387-394.
25. 1A-adrenoceptor subtype by (S)-boldine in rat cerebral cortex. Methods Find. Exp. Clin. Pharmacol., 17, (Suppl. A), 72.
26. 1D- mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol., 115, 981-986.
27. 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens. Br. J. Pharmacol., 111, 1003-1008.
28. 1D-adrenoceptor antagonist, isolated from Fissistigma glaucescens. Br. J. Pharmacol., 112, 1174-1180.
29. 1A-adrenergic receptor. J. Biol. Chem., 266, 6365-6369.
30. LUGNIER, C., BERTRAND, Y. & STOCLET, J.C. (1972). Cyclic nucleotide phosphodiesterase inhibition and vascular smooth muscle relaxation. Eur. J. Pharmacol., 19, 134-136.
31. 1A-adrenoceptor subtype selectivity of 9-O-methylboldine and glaucine in rat cerebral cortex: a structure - activity relationship study. Methods Find. Exp. Clin. Pharmacol., 18, (Suppl. B), 164.
32. 1-adrenoceptor subtypes. Naunyn-Schmiedeherg's Arch. Pharmacol., 352, 1-10.
33. 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB-4101. Mol. Pharmacol., 33, 509-514.
34. 3H] prazosin binding. Mol. Pharmacol., 29, 321-330.
35. MUNSON, P.J. & RODBARD, D. (1980). LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220-239.
36. 3H]-yohimbine to rat renal cortical membranes. Res. Commun. Chem. Path. Pharmacol., 54, 157-171.
37. ORALLO, F., FDEZ ALZUETA, A., CAMPOS-TOIMIL, M. & CALLEJA, J.M. (1995). Study of the in vivo and in vitro cardiovascular effect of (+)-glaucine and N-carbethoxysecoglaucine in rats. Br. J. Pharmacol., 114, 1419-1427.
38. ORALLO, F., FDEZ ALZUETA, A., LOZA, M.I., VIVAS, N., BADIA, A., CAMPOS, M., HONRUBIA, M.A. & CADAVID, M.I. (1993). Study of the mechanism of the relaxant action of (+)-glaucine in rat vas deferens. Br. J. Pharmacol., 110, 943-948.
39. 1-adrenoceptors in mammalian aortae: subclassification based on chlorethylclonidine, WB4101 and nifedipine. J. Vasc. Res., 29, 33-40.
40. 3H]-prazosin in the rat cerebral cortex. Br. J. Pharmacol., 104, 961-965.
41. 1D adrenergic receptor cDNA. Mol. Pharmacol., 40, 876-883.
42. 1A subtype. Mol. Pharmacol., 46, 823-831.
43. 1-adrenoceptors in vascular smooth muscle. Mol. Pharmacol., 46, 30-40.
44. 1-adrenoceptor. Eur. J. Pharmacol., 199, 279-289.
45. 1C-adrenoceptors are the same subtype. Eur. J. Pharmacol., 290, 49-53.
46. REINHARDT, D., ROGGENBACH, W., SCHMIDT, U. & SCHUMANN, H.J. (1977). Effects of papaverine on the frequency-force relationship in guinea-pig left atria. Eur. J. Pharmacol., 41, 123-126.
47. 1D. Biochem. Biophys. Res. Commun., 200, 1177-1184.
48. 1B adrenoceptor subtypes in rat brain cortical membranes. Eur. J. Pharmacol.- Mol. Pharmacol. Sec., 266, 301-308.
49. 1-adrenergic receptor subtype. J. Biol. Chem., 265, 8183-8189.
50. SPEISKY, H., CASSELS, B.K., LISSI, E.A. & VIDELA, L.A. (1991). Antioxidant properties of the alkaloid boldine in systems undergoing lipid peroxidation and enzyme inactivation. Biochem. Pharmacol., 41, 1575-1582.
51. 1B-adrenoceptor subtype. Br. J. Pharmacol., 114, 745-750.
52. 1-adrenoceptor antagonists in rat aorta. Br. J. Pharmacol., 118, 299-310.